Compare Hensel Davest Indonesia Tbk. (HDIT) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hensel Davest Indonesia Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Hensel Davest Indonesia Tbk. trades at Rp50 (market cap 76.23B, 172.7K 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Organon Pharma Indonesia Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.
| HDIT | SCPI | |
|---|---|---|
Market Cap | 76.23B | 104.4B |
Volume | 172.7K | — |
Lot | 1.73K | — |
Turnover | 8.64M | — |
Average Price | 50 | — |
Value | 8.64M | — |
Indicative Equilibrium Price | 50 | — |
Indicative Equilibrium Volume | 1 | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hensel Davest Indonesia Tbk.
PT Hensel Davest Indonesia Tbk (the Company) was established on January 7, 2013 based on Notarial Deed. 01 from Notary Soewandi Michael Barya Sugiyo SH., M.Kn.
Read more on HDIT →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
